CDK7 and head and neck squamous cell carcinoma: Concomitantly, selective CDK7 inhibition led to a significant increase in DNA damage, as indicated by elevated γH2AX levels in HNSCC cells treated with either YKL-5-124 or samuraciclib compared to control cells (Fig. 3i, j).